An investigation on behalf of investors in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares over potential wrongdoing at Arena Pharmaceuticals was announced and NASDAQ:ARNA stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 11/07/2016 -- An investigation on behalf of current long-term investors in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was announced over potential breaches of fiduciary duties by certain directors at Arena Pharmaceuticals.
Investors who purchased shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and currently hold any of those NASDAQ:ARNA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Arena Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.
Arena Pharmaceuticals, Inc. reported that its annual Total Revenue rose from $36.97 million in 2014 to $38.33 million in 2015 while its Net loss increased from $60.51 million in 2014 to $107.98 million in 2015.
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declined from as high as $11.18 per share in July 2012 to as low as $1.48 per share on October31, 2016.
Those who purchased shares of Arena Pharmaceuticals, Inc. have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com